But today’s crypto investors are shifting away from hype-only tokens and toward projects that actually do something. That’s why so […] The post Why Investors Are Leaving Dogecoin and Shiba Inu for LivLive The Presale Calling for 100x Returns appeared first on Coindoo.But today’s crypto investors are shifting away from hype-only tokens and toward projects that actually do something. That’s why so […] The post Why Investors Are Leaving Dogecoin and Shiba Inu for LivLive The Presale Calling for 100x Returns appeared first on Coindoo.

Why Investors Are Leaving Dogecoin and Shiba Inu for LivLive The Presale Calling for 100x Returns

2025/11/04 02:50

But today’s crypto investors are shifting away from hype-only tokens and toward projects that actually do something.

That’s why so many investors are moving into LivLive, the explosive new crypto presale that merges Pokémon GO–style augmented reality, fitness wearables like WHOOP, and real token rewards. LivLive isn’t just a coin; it’s a live-to-earn ecosystem, and analysts are already calling it the best crypto presale of 2025.

Use bonus code EARLY30 at checkout for 30% extra $LIVE.

Dogecoin & Shiba Inu: Fun, Viral but Still Meme Coins

Let’s be clear, Dogecoin and Shiba Inu both had their moment.

  • Dogecoin (DOGE): Launched as a joke, gained major attention thanks to Elon Musk. It still has a strong community, but its utility is limited. Dogecoin doesn’t have a major ecosystem outside of tipping and simple payments.
  • Shiba Inu (SHIB): SHIB attempted to evolve past the “meme coin” label by launching Shibarium and adding a staking ecosystem. But despite these improvements, the token still relies mostly on speculation and hype cycles.

Both coins are popular, both have seen massive pumps, but the reality is hard to ignore:

The meme coin market is saturated.
Investors are now searching for the next big thing, not the same old hype.

With Dogecoin and SHIB struggling to offer anything new, early investors are rotating into projects with real utility and real-world adoption potential.

That’s where LivLive comes in.

LivLive: The Presale Doing What No Other Crypto Has Done

LivLive isn’t trying to be the next meme coin.
It’s becoming the first AR-powered crypto fitness economy.

Here’s what makes the project stand out:

  • Every presale purchase includes an NFT Token Pack and a free LivLive wearable device at launch.
  • The wearable tracks activity and generates $LIVE tokens, scaled by mining power.
  • Users complete real-world AR quests similar to the way Pokémon GO sends users into the world.
  • Instead of earning badges or points, users can earn crypto and real-world rewards.

That means LivLive is not paying you for steps; it pays you for impact.

You explore. You engage. You interact.
You earn.

This system creates a direct link between physical activity, real-world engagement, and token value. No other presale, not Dogecoin, not Shiba Inu, has anything close.

Designed to Reward Early Investors

LivLive has one of the most attractive token allocation structures on the market:

  • 65% of the token supply is dedicated to presale buyers.
  • Everything is transparent, no secret VC allocations.
  • Buyers receive NFT packs, token mining power, and access to a $2.5M rewards pool.

Dogecoin and SHIB didn’t reward early buyers this way.
LivLive does intentionally.

This is why investors are treating LivLive as a second chance at early crypto wealth.

Limited-time offer: 30% extra $LIVE when you use code EARLY30

The Emotional Trigger No One Talks About: Regret

Everyone in crypto has a story.

  • “I could have bought Bitcoin at $300.”
  • “I saw Dogecoin before Elon tweeted about it.”
  • “I hesitated on SHIB and it went 40,000%.”

LivLive is giving investors the feeling they rarely get again:

A project that’s early, new, and actually useful.

This isn’t just hype, it’s meaningful innovation.

LivLive Price Prediction: Can It Really 100x?

Based on market comparisons, analysts see a clear upside.

Tokens in similar categories, fitness, gamification, and AR rewards, have reached enormous valuations because they attract real users, not just traders. Based on projected user growth and token scarcity, LivLive could see:

  • Presale price: around $0.005–$0.01
  • Post-launch upside: $0.50–$1.00 based on demand, user mining, and limited supply

That’s a realistic 50x–100x potential, and that doesn’t include wearable mining rewards.

Crypto is never guaranteed, but unlike Dogecoin and Shiba Inu, LivLive has multiple revenue and adoption drivers, not just hype.

Don’t Miss the Next Big Cycle

LivLive is trending because it’s what crypto needs next:

Real product
Real use case
Rewards for early buyers
Scarcity + demand + hype

Dogecoin and Shiba Inu were great for their era.
LivLive is built for the future.

Get in before the next price increase
Use bonus code EARLY30 for 30% extra $LIVE

You already know the feeling of missing the big one.
This time, act before it explodes.

Find out more information:

  • Website: www.livlive.com    
  • X (Twitter): x.com/livliveapp
  • Telegram: t.me/livliveapp

This publication is sponsored. Coindoo does not endorse or assume responsibility for the content, accuracy, quality, advertising, products, or any other materials on this page. Readers are encouraged to conduct their own research before engaging in any cryptocurrency-related actions. Coindoo will not be liable, directly or indirectly, for any damages or losses resulting from the use of or reliance on any content, goods, or services mentioned. Always do your own research.

The post Why Investors Are Leaving Dogecoin and Shiba Inu for LivLive The Presale Calling for 100x Returns appeared first on Coindoo.

Market Opportunity
BitShiba Logo
BitShiba Price(SHIBA)
$0.0000000004515
$0.0000000004515$0.0000000004515
-0.08%
USD
BitShiba (SHIBA) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23